U.S. Health and Human Services Secretary Xavier Becerra's advice for his likely successor Robert F. Kennedy Jr. includes being prepared for the unexpected, such as deadly viruses and cyberattacks that disable hospitals.

Becerra’s unwavering support for the Affordable Care Act helped land him the top job at the DHS, running a $1.7 trillion agency, developing vaccines and inspecting foods on supermarket shelves.

The former Democrat has faced surprisingly little opposition from Republicans and advocates concerned about his beliefs.

Becerra didn’t mention Kennedy by name Kennedy, but he did offer advice to his prospective replacement. Be worried about the things you can’t see, he said. Cyberattacks that have disabled ...

That's the scene the nation's top health official, Xavier Becerra, wants Americans to remember as he readies to leave the office, possibly to Robert F. Kennedy Jr., President-elect Donald Trump's ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

Robert F. Kennedy Jr. petitioned the FDA to revoke its authorization for the Covid-19 vaccine just six months after it was made available.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all COVID-19 vaccines in May 2021, just as vaccinated Americans began returning to a sense of normalcy after pandemic lockdowns.

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and considered life-saving.

Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drug Ozempic - Any negotiated prices will go into effect in 2027, federal health officials say

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.